These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 2467993)
21. Evidence for at least four antigenic sites on type O foot-and-mouth disease virus involved in neutralization; identification by single and multiple site monoclonal antibody-resistant mutants. McCahon D; Crowther JR; Belsham GJ; Kitson JD; Duchesne M; Have P; Meloen RH; Morgan DO; De Simone F J Gen Virol; 1989 Mar; 70 ( Pt 3)():639-45. PubMed ID: 2471793 [TBL] [Abstract][Full Text] [Related]
22. Neutralizing epitopes of type O foot-and-mouth disease virus. I. Identification and characterization of three functionally independent, conformational sites. Barnett PV; Ouldridge EJ; Rowlands DJ; Brown F; Parry NR J Gen Virol; 1989 Jun; 70 ( Pt 6)():1483-91. PubMed ID: 2471811 [TBL] [Abstract][Full Text] [Related]
23. Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3. Minor PD; Evans DM; Ferguson M; Schild GC; Westrop G; Almond JW J Gen Virol; 1985 May; 66 ( Pt 5)():1159-65. PubMed ID: 2582084 [TBL] [Abstract][Full Text] [Related]
24. Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody-binding site. Blondel B; Crainic R; Fichot O; Dufraisse G; Candrea A; Diamond D; Girard M; Horaud F J Virol; 1986 Jan; 57(1):81-90. PubMed ID: 2416957 [TBL] [Abstract][Full Text] [Related]
25. Generation of a subtype-specific neutralization epitope in foot-and-mouth disease virus of a different subtype. Hernández J; Martínez MA; Rocha E; Domingo E; Mateu MG J Gen Virol; 1992 Jan; 73 ( Pt 1)():213-6. PubMed ID: 1370534 [TBL] [Abstract][Full Text] [Related]
26. Epitope mapping of the outer structural protein VP1 of three different serotypes of foot-and-mouth disease virus. Meloen RH; Barteling SJ Virology; 1986 Feb; 149(1):55-63. PubMed ID: 2418582 [TBL] [Abstract][Full Text] [Related]
27. Epitopes on foot-and-mouth disease virus outer capsid protein VP1 involved in neutralization and cell attachment. Baxt B; Morgan DO; Robertson BH; Timpone CA J Virol; 1984 Aug; 51(2):298-305. PubMed ID: 6205165 [TBL] [Abstract][Full Text] [Related]
28. Antigenic comparison of different foot-and-mouth disease virus types using monoclonal antibodies defining multiple neutralizing epitopes on FMDV A5 subtypes. Saiz JC; Gonzalez MJ; Morgan DO; Card JL; Sobrino F; Moore DM Virus Res; 1989 May; 13(1):45-60. PubMed ID: 2473578 [TBL] [Abstract][Full Text] [Related]
29. Cross-reactive neutralization epitopes on VP3 of human rotavirus: analysis with monoclonal antibodies and antigenic variants. Taniguchi K; Morita Y; Urasawa T; Urasawa S J Virol; 1987 May; 61(5):1726-30. PubMed ID: 2437322 [TBL] [Abstract][Full Text] [Related]
30. Sequence analysis of monoclonal antibody resistant mutants of type O foot and mouth disease virus: evidence for the involvement of the three surface exposed capsid proteins in four antigenic sites. Kitson JD; McCahon D; Belsham GJ Virology; 1990 Nov; 179(1):26-34. PubMed ID: 1699353 [TBL] [Abstract][Full Text] [Related]
31. Selection of antigenic variants of foot-and-mouth disease virus in the absence of antibodies, as revealed by an in situ assay. Diez J; Mateu MG; Domingo E J Gen Virol; 1989 Dec; 70 ( Pt 12)():3281-9. PubMed ID: 2481712 [TBL] [Abstract][Full Text] [Related]
32. Reactivity with monoclonal antibodies of viruses from an episode of foot-and-mouth disease. Mateu MG; Rocha E; Vicente O; Vayreda F; Navalpotro C; Andreu D; Pedroso E; Giralt E; Enjuanes L; Domingo E Virus Res; 1987 Sep; 8(3):261-74. PubMed ID: 2446442 [TBL] [Abstract][Full Text] [Related]
33. Antigenic comparison of foot-and-mouth disease virus serotypes with monoclonal antibodies. Grubman MJ; Morgan DO Virus Res; 1986 Oct; 6(1):33-43. PubMed ID: 3026110 [TBL] [Abstract][Full Text] [Related]
34. Antigenic variation among foot-and-mouth disease virus type A field isolates of 1997-1999 from Iran. Marquardt O; Freiberg B Vet Microbiol; 2000 Jun; 74(4):377-86. PubMed ID: 10831859 [TBL] [Abstract][Full Text] [Related]
35. [Synthetic peptides simulating the protective epitopes of VP1 protein of foot-and-mouth disease virus type O and A]. Surovoĭ AIu; Vol'pina OM; Ivanov VT; Chepurkin AV; Ivaniushchenkov VN Bioorg Khim; 1987 Aug; 13(8):1132-5. PubMed ID: 2445357 [TBL] [Abstract][Full Text] [Related]
36. Antigenic features of foot-and-mouth disease virus serotype Asia1 as revealed by monoclonal antibodies and neutralization-escape mutants. Sanyal A; Venkataramanan R; Pattnaik B Virus Res; 1997 Aug; 50(2):107-17. PubMed ID: 9282776 [TBL] [Abstract][Full Text] [Related]
37. Antigenic heterogeneity of a foot-and-mouth disease virus serotype in the field is mediated by very limited sequence variation at several antigenic sites. Mateu MG; Hernández J; Martínez MA; Feigelstock D; Lea S; Pérez JJ; Giralt E; Stuart D; Palma EL; Domingo E J Virol; 1994 Mar; 68(3):1407-17. PubMed ID: 8107204 [TBL] [Abstract][Full Text] [Related]
38. Monoclonal antibodies to an Indian strain of type A foot-and-mouth disease virus. Tosh C; Venkataramanan R; Pattnaik B; Hemadri D; Sanyal A Acta Virol; 1999 Aug; 43(4):219-25. PubMed ID: 10749367 [TBL] [Abstract][Full Text] [Related]
39. Distinct repertoire of antigenic variants of foot-and-mouth disease virus in the presence or absence of immune selection. Borrego B; Novella IS; Giralt E; Andreu D; Domingo E J Virol; 1993 Oct; 67(10):6071-9. PubMed ID: 7690417 [TBL] [Abstract][Full Text] [Related]
40. Antigenic mapping of the surface proteins of rhesus rotavirus. Shaw RD; Vo PT; Offit PA; Coulson BS; Greenberg HB Virology; 1986 Dec; 155(2):434-51. PubMed ID: 2431540 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]